Trade LYEL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Lyell Immunopharma, Inc. (LYEL) is trading at US$14.54, down 0.49% today as of Aug 28, 12:59 EDT. The company has a market capitalisation of US$380.56M. Over the past 52 weeks, LYEL has traded between US$10.76 and US$45.00. On Syfe you can trade LYEL with $0 commission and add it to your watchlist.
| Previous close | US$14.61 |
|---|---|
| Market cap | US$380.56M |
| 52-week range | US$10.76 – US$45.00 |
| Volume | 88.38K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Year: 2021
B. Riley Initiates Lyell Immunopharma at Buy With $44 Price Target
Jul 22, 11:58 AM · MT Newswires
Lyell Immunopharma Files for Secondary Offering of Common Shares
Jul 13, 9:30 PM · MT Newswires
Lyell Immunopharma's Cancer Therapy Shows Improved Safety in Phase 1 Study
Jun 8, 10:46 AM · MT Newswires
Baird Initiates Lyell Immunopharma at Outperform With $49 Price Target
May 1, 11:30 AM · MT Newswires
Lyell Immunopharma, Inc. (LYEL) stock is trading at US$14.54, -0.49% from the previous close of US$14.61.
The market cap for Lyell Immunopharma, Inc. (LYEL) stock is approximately US$380.56M.
The 52-week high for Lyell Immunopharma, Inc. (LYEL) stock is US$45.00.
The 52-week low for Lyell Immunopharma, Inc. (LYEL) stock is US$10.76.
Lyell Immunopharma, Inc. (LYEL) does not currently pay a dividend.
Stay on top of LYEL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
